Cardiac myoglobin deficit has evolved repeatedly in teleost fishes

Myoglobin (Mb) is the classic vertebrate oxygen-binding protein present in aerobic striated muscles. It functions principally in oxygen delivery and provides muscle with its characteristic red colour. Members of the Antarctic icefish family (Channichthyidae) are widely thought to be extraordinary for lacking cardiac Mb expression, a fact that has been attributed to their low metabolic rate and unusual evolutionary history. Here, we report that cardiac Mb deficit, associated with pale heart colour, has evolved repeatedly during teleost evolution. This trait affects both gill- and air-breathing species from temperate to tropical habitats across a full range of salinities. Cardiac Mb deficit results from total pseudogenization in three-spined stickleback and is associated with a massive reduction in mRNA level in two species that evidently retain functional Mb. The results suggest that near or complete absence of Mb-assisted oxygen delivery to heart muscle is a common facet of teleost biodiversity, even affecting lineages with notable oxygen demands. We suggest that Mb deficit may affect how different teleost species deal with increased tissue oxygen demands arising under climate change.     

It started with a dream: Paul's dream (Acts 16,9?10) and Aeneas as a biblical example of dreams as intercultural legitimation strategy.

Dreams are often used to promote religion, or to propagate an interpretation of religion, or to bring political ideas to the fore. A dream can be used as an indication of divine help and thus it is a perfect tool for promoting ideas. Dreams figure in religious propaganda in Christian, Jewish, and Muslim traditions (e.g., in Osama bin Laden's tapes). In classical literature, we find many kings, emperors, or generals who had visions or dreams, especially in association with their accession to power. It is the thesis of this article that in the encounter between Jewish (-Christian) cultures and the Hellenistic world dreams were shared as possible means of divine communication. An important example is the dream in Acts 16,9?10, the most Hellenistic dream of the New Testament. This dream is part of a larger unit, Paul's new move from Asia to Europe. I will try to show that the author of Acts combines here the story of Aeneas (e.g., as told by Virgil) and the story of Jesus, an interesting merging of two cultures. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Percutaneous fine needle aspiration biopsy of the lung. A study of 1,015 patients

From the time of its introduction, in 1973, through November 1983, fine needle aspiration biopsy ( FNAB ) of the lung was used in the diagnostic evaluation of 1,015 patients at the Duke University Medical Center and Durham Veterans Administration Medical Center. A diagnosis of a primary lung cancer was established in 49.4% of the cases and malignant neoplasm metastatic to the lung in 14.1%; a benign diagnosis was made in 31.1% and an inconclusive one in 5.4%. In 123 patients in whom lung tissue was also available, cancer was correctly diagnosed by FNAB in 83.8%, not diagnosed by FNAB in 14.6% and incorrectly diagnosed in 1.6%. In 37 patients without cancer, FNAB detected an infectious organism or a specific morphologic type of inflammation (abscess and granuloma).     

GABA UPTAKE IN RAT BRAIN SLICES: INHIBITION BY GABA ANALOGUES AND BY VARIOUS DRUGS

Abstract— 2-Hydroxy-, 2-chloro-, 2- and Cmethyl-GABA are linear competitive inhibitors of GABA uptake in rat brain slices. These analogues are thus potential substrates for the GABA transport system and possible'false transmitters'. 2-Hydroxy-GABA is the most potent inhibitor of GABA uptake yet described. No specific inhibitor of GABA uptake was revealed amongst the drugs tested.     

Reduction in size of prolactin-secreting tumours in men treated with pergolide.

The effect of pergolide mesylate was studied in two previously untreated men with large prolactinomas and exceptionally high prolactin concentrations. The study was designed to determine whether pergolide would be effective in alleviating symptoms, correcting hormonal abnormalities and shrinking the tumour. Starting with 50 micrograms daily the dose of pergolide was slowly increased over 10 weeks to 1 mg once daily, when repeat assessment was performed. Both patients reported complete relief of symptoms, with no side effects. Serum prolactin concentration was suppressed to normal in both subjects, and evidence to suggest tumour shrinkage was observed. Pergolide appears to be effective treatment for men with large prolactinomas.